US State Department has said it is engaging with Chinese officials to resolve situation | Federal employee failed to disclose ...

Court delivers default judgment dismissing EOFlow’s patent revocation claim | Dispute escalates following EOFlow’s refusal to ...

Design and colour combination deemed ‘too common’ in the pharma sector for protection | Court says trademarks must be ...

Court of Appeal backs Astellas in UK patent fight over prostate cancer drug | Generics’ challenge fails as judges warn on ...

Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | ...

27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

The Arusha Protocol is a catalyst for agricultural transformation. It provides legal assurance and financial incentives for ...

$56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues. Already ...

29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical ...

31 March 2025 With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its ...

After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...